Aurones serve as probes of -amyloid plaques in Alzheimer's disease.


A novel series of aurone derivatives for in vivo imaging of -amyloid plaques in the brain of Alzheimer's disease (AD) were synthesized and characterized. When in vitro binding studies using A(1-42) aggregates were carried out with aurone derivatives, they showed high binding affinities for A(1-42) aggregates at the Ki values ranging from 1.2 to 6.8 nM. When in vitro plaque labeling was carried out using double transgenic mice brain sections, the aurone derivatives intensely stained -amyiloid plaques. Biodistribution studies in normal mice after i.v. injection of the radioiodinated aurones displayed high brain uptake (1.9-4.6% ID/g at 2 min) and rapid clearance from the brain (0.11-0.26% ID/g at 60 min), which is highly desirable for amyloid imaging agents. The results in this study suggest that novel radiolabeled aurones may be useful amyloid imaging agents for detecting -amyloid plaques in the brain of AD.